Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate
Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
Our project is a 24-month longitudinal randomized controlled trial that aims to investigate
the myopia development after topical application of 0.01% atropine in children with either
fast or slow myopia progression classified according to their initial electro-retinal
responses. This will help elucidate the effectiveness of using low concentration atropine for
myopia control in children with different myopia progression rates.